Tag: GlobeNewswire

Partnership opens a new commerce channel, starting with approximately 20 million LG Smart TVs in the U.S.; restaurants to be the first category of focus

SANTA CLARA, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) — SoundHound AI, Inc. (Nasdaq: SOUN), a global leader in voice and agentic AI, today announced a strategic partnership with LG Electronics to expand restaurant and merchant participation on LG Smart TVs in the United States. The collaboration lays the groundwork for a new commerce channel in the living room.

The partnership gives participating businesses a new way to reach customers in the home, with an initial footprint of approximately 20 million LG Smart TVs in the U.S. Restaurants will be the first category of focus, with plans to extend to retail and other merchant categories over time.

SoundHound is working with restaurant brands interested in participating as the ecosystem develops. Its platform already serves leading brands across thousands of locations, including Jersey Mike’s, Five Guys, and White Castle.

A New Frontier for Living Room Commerce

This initiative sets the stage for the living room TV to become a transaction channel for restaurant operators and merchants, and for a better overall commerce experience for the consumers they serve. It builds on SoundHound’s merchant network, which handles transaction routing and secure checkout.

For SoundHound, the partnership expands on the commercial channel it debuted at CES 2025. Over time, the company plans to broaden the commerce experiences it supports, bringing its roster of brands from across hospitality, travel, entertainment, banking and more to the smart devices it powers.

“The TV is the largest screen in the most social setting of every home, which makes it a highly untapped opportunity for commerce,” said Keyvan Mohajer, CEO and Co-Founder of SoundHound AI. “This partnership with LG lays the foundation for how brands can engage with audiences in the living room. By bringing commerce to smart screens, we see an opportunity to create an entirely new channel for merchants.”

Value for Restaurant & Retail Partners

For national quick service restaurant chains, local restaurant groups, and retail brands, commerce on the living room TV represents a way to reach customers where they spend their time.

SoundHound’s approach is designed to offer:

• Direct Customer Engagement: A new way to engage households, starting with approximately 20 million LG Smart TVs in the U.S., during peak dining and viewing windows.
• Zero Additional Hardware: Requires no new in-store hardware for participating restaurants.
• Seamless Integration: Integrates directly with the Point of Sale (POS) and kitchen execution systems restaurants already use.

SoundHound currently works with over 15,000 restaurant locations across the U.S. The company invites restaurant brands, national food chains, and retail partners to learn more about participating by visiting: www.soundhound.com/join-lg-electronics-smart-tv-commerce-ecosystem

About SoundHound AI
SoundHound AI (Nasdaq:SOUN) is a voice and agentic AI company that enables businesses to deliver natural, end-to-end conversational experiences across digital and physical channels, including phones, kiosks, chat, smart devices, drive-thrus, TVs, in-vehicle, and more. Its agentic platform, OASYS, is a self-learning, orchestrated AI system where organizations can build and deploy conversational AI agents to handle transactions, tasks, and workflows on behalf of customers and employees. Built on proprietary technology backed by 750+ patents and years of AI research, SoundHound serves leading brands across industries including automotive, financial services, healthcare, retail, telecommunications, and more. It powers millions of products and processes billions of interactions annually for enterprise customers worldwide. Learn more at: www.soundhound.com

Media:
Fiona McEvoy
415-610-6590
PR@SoundHound.com

Hofseth BioCare ASA (“HBC”) announces that its US spin-out AecorBio Inc. (“AecorBio”) has appointed Prof. Karl G. Sylvester, M.D., as Co-Founder and Consulting Chief Medical Officer. Dr. Sylvester is Professor of Surgery at Stanford University School of Medicine and has advised AecorBio on the clinical strategy for FT-002a-O since 2025.

In connection with Dr. Sylvester’s appointment at AecorBio, he has been granted share options for 972,491 shares of AecorBio’s Class C Common Stock, corresponding to approximately 9% of the currently outstanding shares in AecorBio. If these share options are exercised, the delivery of the shares is currently intended to be handled through a surrender of a corresponding number of shares of Class C Common Stock held by HBC. Together with previously granted share options, Dr. Sylvester will hold share options in AecorBio for 1,047,491 shares.

AecorBio’s full announcement, including an update on the FT-002a-O development programme, is available at https://aecorbio.com/#news/sylvester-cmo

For further information, please contact:
Dr. Crawford Currie, Head of Medical R&D at Hofseth BioCare ASA
Phone: +44 7968 195 497
E-mail: cc@hofsethbiocare.no

James Berger, Chief Commercial Officer at Hofseth BioCare ASA
Phone: +41 79 950 1034
E-mail: jb@hofsethbiocare.no

About Hofseth BioCare ASA:
Hofseth BioCare is a Norwegian consumer and pet health company founded on the core values of sustainability, optimal utilization of natural resources and full traceability. It upcycles the side streams of the salmon industry, taking fresh filleted salmon and converting it from a waste product into ingredients to improve human and pet health. These ingredients are ProGo®, a mix of bioactive peptides and collagen; OmeGo®, a whole salmon oil containing all the fatty acid fractions found in fish; and CalGo®/NT-II® salmon bone powder containing calcium hydroxyapatite and undenatured collagen for bone and joint health. HBC places scientific evidence at the forefront, which has led to important academic partnerships and the identification of unique health benefits. HBC is listed on Oslo Stock Exchange with ticker “HBC”.

This information is considered to be inside information pursuant to the EU Market Abuse Regulation (MAR) and is subject to the disclosure requirements pursuant to Article 17 of MAR and Section 5-12 of the Norwegian Securities Trading Act. This stock exchange announcement was published by Jon Olav Ødegård, CEO, on the time and date provided.

The New Energy Group EPSO-G (company code 302826889, registered office at Laisvės pr. 10, Vilnius, Lithuania) has announced the selection of board members for the new term of the Group company Tetas. Candidates are invited to submit their documents by 3 December 2026 inclusive.

The selection will seek two independent board members with competencies in commercial and contracting operations management. The members nominated by EPSO-G will be selected for the areas of financial management and control, project management, and organisational development and operational efficiency.

The board of Tetas, an energy infrastructure development and maintenance company, consists of five members elected for a four-year term. The term of the current board will end on 21 March 2027.

To ensure good governance and proper representation of the shareholder, the board will include two independent board members and three board members nominated by the parent company EPSO-G. The combination of different competencies will enable the board to assess the company’s operational decisions comprehensively and oversee their implementation.

The selection of independent board members is conducted by a five-member Selection Committee, consisting of three representatives of EPSO-G, one representative of the Ministry of Energy and one representative of the Governance Coordination Centre. The executive search agency J. Friisberg & Partners has been engaged for the selection. The Committee will submit recommendations on the selected candidates to the General Meeting of Shareholders.

The selection procedures for board members nominated by EPSO-G are carried out, and recommendations to the General Meeting of Shareholders are submitted, by the EPSO-G Remuneration and Nomination Committee.

The requirements for candidates and the application procedure can be found here: https://epsog.lt/wp-content/uploads/2026/11/TETAS-valdybos-nariu-atrankos-skelbimas_2026-11-03.pdf

The EPSO-G group of companies consists of the management company EPSO-G and six directly controlled companies: Amber Grid, Baltpool, Energy cells, EPSO-G Invest, Litgrid and Tetas. EPSO-G and its Group companies also hold shares in Rheinmetall Defence Lietuva, Baltic RCC OÜ and TSO Holding AS. The rights and obligations of the sole shareholder of EPSO-G are exercised by the Ministry of Energy of the Republic of Lithuania.

Considering that during the shares buy-back process of INVL Technology (hereinafter – “the Company”), the Company acquired 543,571 shares for EUR 2,999,859.61 from the Company’s shareholders for which they were paid on 30 October 2026, the Company announces the data on shares issued by the Company as of 30 October 2026:

Type of shares	Number of shares and total voting rights granted by the issued shares, units	Number of votes for the quorum of the General Shareholders Meeting, units	Nominal value, EUR	Total nominal value and authorized capital, EUR	Portion of the authorized capital, %
Ordinary registered shares	12,175,321	11,434,829	0.29	3,530,843.09	100

The person authorized to provide additional information: 
INVL Technology Managing Partner 
Kazimieras Tonkūnas 
E-mail  k.tonkunas@invltechnology.lt

New Energy Group EPSO-G (legal entity code 302826889, registered office address Laisvės pr. 10, Vilnius, Lithuania)

EPSO-G Invest, the EPSO-G group’s company managing investments in the defence industry, announces a public selection process for the position of CEO. Applications for this position may be submitted until 03-12-2026 inclusive.

In line with the highest standards of transparency and good governance practices, representatives of both shareholders of EPSO-G Invest will participate in the candidate selection process: the EPSO-G Remuneration and Nomination Committee, in which independent members form the majority, and a representative of Valstybės investicinis kapitalas. The selection process will be conducted by the recruitment agency AIMS International Lietuva.

Once the selection procedures have been completed and the candidates have been vetted in accordance with the requirements of the Law on the Protection of Objects of Importance to Ensuring National Security and the Law on the Prevention of Corruption, the decision on the appointment of the CEO from among the selected candidates will be made by the general meeting of shareholders of EPSO-G Invest.

EPSO-G Invest is a company of the new energy group EPSO-G, 51% of whose shares are held by EPSO-G and the remaining 49% by Valstybės investicinis kapitalas.

The requirements for candidates and the application procedure can be found here: EPSO-G-Invest-vadoves-o-skelbimas_2026-11-03.pdf

The EPSO-G group of companies consists of the holding company EPSO-G and its six direct subsidiaries Amber Grid, Baltpool, Energy cells, EPSO-G Invest, Litgrid and Tetas. EPSO-G and its Group companies also hold shares in Rheinmetall Defence Lietuva, Baltic RCC OÜ and TSO Holding AS. The rights and obligations of the sole shareholder of EPSO-G are exercised by the Ministry of Energy of the Republic of Lithuania.

The retail turnover (including VAT) of the Apranga Group amounted to EUR 36.1 million in October 2026 and increased by 4.1% compared to October 2025.

The retail turnover (including VAT) of Apranga Group reached EUR 326.9 million in January-October 2026 and increased by 8.8% compared to the corresponding period of 2025.

In January-October 2026, the retail turnover of Apranga Group in Lithuania increased by 10.6% year-to-year, in Latvia increased by 5.9% and increased by 6.4% in Estonia.

Currently Apranga Group operates the chain of 174 stores (103 in Lithuania, 44 in Latvia, and 27 in Estonia) with a total area of 93.7 thousand sq. m., or by 1.1% more than a year ago.

Rimantas Perveneckas
„Apranga“ Group General Manager
+370 5 2390801

– Company to Host Conference Call on November 10, 2026, at 4:30 p.m. ET –

SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that it will release its financial results for the third quarter ended September 30, 2026, after the market close on Tuesday, November 10, 2026. Management will host a conference call and webcast at 4:30 p.m. ET that same day.

Title:	Capricor Therapeutics Third Quarter 2026 Financial Results and Recent Corporate Update Conference Call and Webcast
Date:	Tuesday, November 10, 2026
Time:	4:30 p.m. ET
Call Details:	Toll-Free: 1-800-717-1738
	International: 1-646-307-1865
	Conference ID: 13662
	Participants may dial in using the numbers above and ask to be joined to the call, or use the Call me™ link for instant telephone access to the event.
Webcast:	Click here

A replay of the webcast will be available shortly after the conclusion of the live event and will be accessible in the Investors section of the Company’s website at www.capricor.com.

About Capricor Therapeutics

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing cell and exosome-based therapeutics for the treatment of rare diseases. Our lead product candidate, Deramiocel, is an allogeneic cardiac-derived cell therapy in late-stage development for the treatment of Duchenne muscular dystrophy (DMD), evaluated in clinical studies for its potential to preserve skeletal and cardiac muscle function. Capricor is also advancing its proprietary StealthX™ exosome platform for the targeted delivery of oligonucleotides, proteins, and small-molecule therapeutics across a range of diseases. At Capricor, we are committed to delivering new therapies for patients with rare diseases. For more information, visit capricor.com and follow Capricor on Facebook, Instagram and X.

Cautionary Note Regarding Forward-Looking Statements

Statements in this press release regarding the efficacy, safety, and intended utilization of Capricor’s product candidates; the initiation, conduct, size, timing and results of clinical trials; the pace of enrollment of clinical trials; plans regarding regulatory filings, future research and clinical trials; regulatory developments involving products, including future interactions with regulatory authorities and the ability to obtain regulatory approvals or otherwise bring products to market; manufacturing capabilities; dates for regulatory meetings; the potential that required regulatory inspections may be delayed or not be successful, which would delay or prevent product approval; revenue and reimbursement estimates; projected terms of definitive agreements, our financial position, our possible uses of existing cash and investment resources; results of securities litigation; and statements regarding our litigation with Nippon Shinyaku Co., Ltd. and NS Pharma, Inc., including the nature of the dispute, our expectations regarding any legal proceedings, and our ability to commercialize Deramiocel independent of our existing distribution agreement and any other statements about Capricor’s management team’s future expectations, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “believes,” “plans,” “could,” “anticipates,” “expects,” “estimates,” “should,” “target,” “will,” “would” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements. More information about these and other risks that may impact Capricor’s business is set forth in Capricor’s Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission on March 17, 2026 and in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, as filed with the Securities and Exchange Commission on August 14, 2026. All forward-looking statements in this press release are based on information available to Capricor as of the date hereof, and Capricor assumes no obligation to update these forward-looking statements.

Deramiocel and Capricor’s StealthX™ exosome therapeutics are investigational and have not been approved for commercial use in any indication.

For more information, please contact:

Capricor Media Contact:
Caitlin Kasunich / Raquel Cona
KCSA Strategic Communications
ckasunich@kcsa.com / rcona@kcsa.com
212.896.1241 / 516.779.2630

Capricor Company Contact:
AJ Bergmann, Chief Financial Officer
abergmann@capricor.com
858.727.1755

Following a court-supervised restoration, NUGS plans to combine with Scopien, a sovereign AI platform

LOS ANGELES, Nov. 03, 2026 (GLOBE NEWSWIRE) — Cannabis Strategic Ventures, Inc. (OTC: NUGS) (“NUGS” or the “Company”) today announced that it signed a binding letter of intent (the “LOI”) with Scopien Technologies Inc. (“Scopien”), an Ontario corporation. Under the LOI, Scopien would acquire voting control of NUGS through the transfer of the Company’s Series B Super Voting Preferred Stock and contribute its operating business to the Company. The parties intend to complete the change of control by November 30, 2026.

Termination of Adport Letter of Intent

The Company also announced that it has terminated the non-binding letter of intent with Adport Inc. announced on September 10, 2026, under which the Company had proposed to acquire substantially all of Adport’s intellectual property and operating assets. No definitive agreements were entered into with Adport.

About the Scopien Platform

Scopien connects a company’s systems, including CRM, ERP, HR, payroll and helpdesk, into one operating platform and puts AI agents to work across it. Each customer runs its own instance in Scopien’s cloud, its own cloud or on-premises, so data stays inside its walls. Scopien serves mid-market companies, enterprises and government, and plans to expand its sales and partner channels, product modules and engineering program.

What Comes Next

When the change of control closes, Scopien would appoint NUGS’s officers and directors. The Company intends to change its name and trading symbol to reflect the Scopien business, subject to FINRA processing, and to complete PCAOB audits and file a registration statement with the SEC within six months following the change of control, with the goal of becoming a fully reporting company and pursuing a Nasdaq or NYSE listing.

“We rebuilt this company through the courts so shareholders would have something real to build on,” said Richard C. Hawkins, Chief Executive Officer of NUGS. “Scopien is the kind of company we hoped to find.”

“Every business should work as one,” said Zameer Mulla, Chief Executive Officer of Scopien. “Being a public company holds us to the standard of transparency our customers expect. Our first priority is completing the audit and the registration statement.”

Court Custodianship

In July 2025, the Eighth Judicial District Court of Nevada, Clark County, appointed a custodian for the Company, which at the time had no operations and carried more than $14.6 million in legacy liabilities. The custodian reinstated the Company, ran a court-supervised creditor-notice process and, in December 2025, obtained an order barring unasserted claims. In April 2026, the Court ratified the custodian’s actions and returned control to the board. Total reported liabilities were approximately $491,000 at September 30, 2026, and all legacy Series C Preferred Stock has been cancelled.

About Scopien Technologies Inc.

Scopien Technologies Inc., based in Oakville, Ontario, builds sovereign AI that makes every business work as one. For more information, visit www.scopien.com.

About Cannabis Strategic Ventures, Inc.

Cannabis Strategic Ventures, Inc. is a Nevada corporation quoted on OTC Markets under the symbol “NUGS.” Following a court-supervised custodianship completed in April 2026, the Company is pursuing business combinations with operating businesses that have growth potential.

Investor Contact

info@cannabisstrategic.ventures | +1 480-788-7420

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding the proposed change of control, the contribution of Scopien’s business, the audit and registration statement, and potential exchange listing. These statements are subject to significant risks and uncertainties, including: that definitive agreements may not be executed or the LOI may be terminated; that the audit and registration statement may not be completed as contemplated; that Scopien’s business may not grow as anticipated; that additional funding may not be available; that securities remain subject to former-shell-company resale restrictions under Rule 144(i); that exchange listing standards may not be met; and that legacy indebtedness and future financing may substantially dilute common stockholders. The super-voting preferred stock would concentrate voting control in Scopien.

The safe harbor provided by Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 is not available to the Company. The Company undertakes no obligation to update any forward-looking statement except as required by law. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Source: Cannabis Strategic Ventures, Inc.

DALIAN, China, Nov. 03, 2026 (GLOBE NEWSWIRE) — CBAK Energy Technology Limited (NASDAQ: CBAT) (“CBAK Energy” or the “Company”), a China-based lithium-ion battery manufacturer and energy solutions provider, today reported that a battery pack manufacturer serving the automated guided vehicle (“AGV”) market has placed orders totaling approximately US$8.22 million, including applicable taxes, since their commercial relationship began in 2022. Initial battery cell evaluations took place in 2021. The customer purchases CBAK Energy’s 26650 PFS2 and 32140 FS full-tab cylindrical lithium iron phosphate (“LFP”) cells for AGV battery packs. AGVs are mobile robots that transport materials in warehouses and manufacturing facilities.

The Power Demands of AGVs

AGVs often operate across extended shifts with frequent starts, stops and changing loads. These conditions require consistent power delivery, while short charging windows make fast recharging important for reducing downtime. Limited battery space also places demands on pack design and thermal management. Battery pack manufacturers must balance power, charging speed, cycle life and space requirements for each application.

LFP Cells for AGV Battery Packs

For compact warehouse AGVs that move and recharge frequently, CBAK Energy’s 26650 PFS2 full-tab cylindrical LFP cell offers high-rate charging and discharging and achieved a cycle life of 3,000 cycles in Company testing. Its full-tab design helps reduce internal resistance and heat generation during high-current operation. The smaller cylindrical format also gives battery pack manufacturers flexibility when fitting cells into limited space.

For AGVs with higher energy requirements, the Company offers its 32140 FS large cylindrical LFP cell. In Company testing, the cell’s internal resistance was 1.3 mΩ, approximately 18% lower than that of comparable cells tested. It supports 2C fast charging and reached a full charge in approximately 30 minutes under specified test conditions. Its larger format can help reduce the number of cells needed for a battery pack, depending on the required energy capacity and pack design. These features make it an option for AGVs operating on longer routes, carrying heavier loads or working with short charging windows.

Customer Qualification and Ongoing Supply

CBAK Energy’s 26- and 32-series cylindrical LFP cells have passed the customer’s initial safety and performance evaluations. The Company draws on more than two decades of battery manufacturing experience, established quality controls and production capacity in Nanjing and Dalian to support ongoing supply. Its product testing and compliance practices address applicable UL safety standards, UN 38.3 transport testing and RoHS restrictions on hazardous substances. These capabilities support the customer’s qualification process and development of battery packs for different AGV applications.

“AGV applications are an important market for our cylindrical LFP cells,” said Zhiguang Hu, Chief Executive Officer of CBAK Energy. “Our relationship with this customer has grown from initial evaluations into several years of supply. It shows the commercial value of meeting demanding operating requirements while maintaining consistent product quality. Battery pack manufacturers need both suitable cells and a dependable supplier as their applications evolve. We intend to build on this experience to develop our product range and win more business in warehouse, logistics and manufacturing automation.”

About CBAK Energy

CBAK Energy Technology Limited (NASDAQ: CBAT) is a China-based company that develops, manufactures and sells high-power lithium-ion and sodium-ion batteries, as well as materials used in high-power lithium-ion batteries. It has battery cell production, research and development, and sales operations in Nanjing, Dalian and Shangqiu, with research and development centers in Nanjing and Dalian. Its raw materials business is based in Shaoxing. The Company’s products serve electric vehicles, light electric vehicles, energy storage systems and other high-power applications. In January 2006, CBAK Energy became the first Chinese lithium battery manufacturer to be listed on the Nasdaq Stock Market.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements include expectations regarding the continued development of the Company’s relationship with its AGV battery pack customer; order fulfillment, future customer demand, product qualification and supply opportunities; the suitability and expected performance of its cylindrical LFP cells in AGV applications; the potential benefits of cell design, fast charging, high-rate discharge and cycle life; the Company’s ability to maintain product quality and reliable supply; and its plans to develop its product range and expand its business in warehouse, logistics and manufacturing automation.

Words such as “expect,” “estimate,” “anticipate,” “believe,” “intend,” “plan,” “target,” “may,” “will,” “would” and “could,” and similar expressions, identify forward-looking statements. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially.

Risks include changes in customer demand, AGV market conditions and product requirements; the timing of order fulfillment and delivery; the outcome of customer testing and qualification; whether existing relationships lead to additional orders or expanded supply; differences between cell test results and actual battery pack or AGV performance; variations in charging time, cycle life and internal resistance under different conditions; manufacturing yields, product quality, production capacity and supply availability; battery pack design and charging strategies; applicable safety, certification, transportation and environmental requirements; competing battery technologies; and other risks described in the Company’s reports filed with or furnished to the U.S. Securities and Exchange Commission.

The cell performance figures in this release were obtained in Company testing under specified conditions. The comparative result applies to the cells tested. Actual battery pack and AGV performance, including charging time and cycle life, will depend on pack design, charging protocols, operating conditions, usage patterns and other factors.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Except as required by applicable law, the Company undertakes no obligation to update or revise any forward-looking statements as a result of new information, future events or otherwise.

For more information, please visit: https://en.cbak.com.cn/
Email: marketing@cbak.com.cn
LinkedIn: https://www.linkedin.com/company/cbakenergy
X: https://x.com/CBAKEnergy
Stocktwits: https://stocktwits.com/CBAK_Energy
Investor Relations
Email: ir@cbak.com.cn
Website: https://ir.cbak.com.cn/

Marcela Ronquillo Hinojosa to Support Strategic Partnerships, Financing Opportunities and Development of Hydrogen and CNG Infrastructure

Dallas, TX, Nov. 03, 2026 (GLOBE NEWSWIRE) — Vivakor, Inc. (Nasdaq: VIVK) (“Vivakor” or the “Company”), an integrated provider of energy transportation, storage, reuse and remediation services, today announced the engagement of international business strategist Marcela Ronquillo Hinojosa as a strategic consultant to support the development of the Company’s proposed hydrogen and compressed natural gas (“CNG”) infrastructure project at a major international airport in Texas.

The engagement follows Vivakor’s recent announcement of a nonbinding letter of intent to pursue a long-term lease of approximately 12.9 acres at the airport for the development of hydrogen and CNG fueling infrastructure, with potential future expansion into hydrogen production using airport-generated organic waste.

Ms. Ronquillo Hinojosa brings more than 20 years of experience in international business development, strategic partnerships and sustainable infrastructure. In her consulting role, she is expected to assist Vivakor in developing strategic relationships, identifying prospective financing opportunities and coordinating partnerships to support the advancement of the proposed airport project.

“Developing a project of this scale requires strong strategic partnerships and access to capital,” said James Ballengee, Chairman, President and Chief Executive Officer of Vivakor. “Marcela brings extensive international relationships and experience connecting businesses, financial institutions and government stakeholders. We believe her involvement will help us establish the commercial and financial relationships necessary to move this initiative forward.”

Ms. Ronquillo Hinojosa is the Founder and Chief Executive Officer of NewSpace Capital LLC, which develops and structures sustainable infrastructure initiatives, and Earth Carbon LLC, which focuses on ecosystem conservation and carbon market development. She also serves as Vice President of COMENER, the Mexican Energy Council, and previously served as Executive Director of EarthX Latin America, where she facilitated collaboration among corporations, governments and international organizations on sustainability initiatives.

“Vivakor’s proposed airport energy infrastructure project presents an exciting opportunity to bring together sustainable energy solutions and strategic investment,” said Ms. Ronquillo Hinojosa. “I look forward to leveraging my relationships and experience to help establish partnerships, identify financing opportunities and support the long-term success of this initiative.”

About Vivakor, Inc.

Vivakor, Inc. is an integrated provider of sustainable energy transportation, storage, reuse, and remediation services. Its corporate mission is to develop, acquire, accumulate, and operate assets, properties, and technologies in the energy sector. Vivakor’s integrated facilities assets provide crude oil, storage, transportation, reuse, and remediation services under long-term contracts. Once operational, Vivakor’s interest in oilfield waste remediation facilities will facilitate the recovery, reuse, and disposal of petroleum byproducts and oilfield waste products.

For more information, please visit our website: http://vivakor.co

Cautionary Statement Regarding Forward-Looking Statements
This news release may contain forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing of events may differ materially from the results anticipated in these forward-looking statements. Forward-looking statements may be identified but not limited by the use of the words “anticipates,” “expects,” “intends,” “plans,” “should,” “could,” “would,” “may,” “will,” “believes,” “estimates,” “potential,” or “continue” and variations or similar expressions. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including, but not limited to, the expected transaction and ownership structure, the valuation of the transaction, the likelihood and ability of the parties to successfully and timely consummate planned acquisitions, the risk that any required regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect Vivakor or the expected benefits of the such transaction, our ability to maintain the listing of our securities on The Nasdaq Capital Market, the parties failure to realize the anticipated benefits of pending transactions, disruption and volatility in the global currency, capital, and credit markets, changes in federal, local and foreign governmental regulation, changes in tax laws and liabilities, tariffs, legal, regulatory, political and economic risks, our ability to successfully develop products, rapid change in our markets, changes in demand for our future products, and general economic conditions.

These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor’s filings with the U.S. Securities and Exchange Commission, which factors may be incorporated herein by reference. Actual results, performance or achievements may differ materially, and potentially adversely, from any projections and forward-looking statements and the assumptions on which those forward-looking statements are based. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as projected financial information and other information are based on estimates and assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond our control. All information set forth herein speaks only as of the date hereof in the case of information about Vivakor or the date of such information in the case of information from persons other than Vivakor, and we disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this communication. Forecasts and estimates regarding the industries and markets are based on sources we believe to be reliable; however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.

Investor Contact:
P:469-480-7175
info@vivakor.com